Venue: Room XXIV of Palais des Nations, Geneva

The Global Health Innovative Technology Fund (GHIT Fund), launched on 8 April 2013, is bringing Japanese leadership in health and technology innovation – from its public and private sectors – to the global fight against diseases that disproportionately affect the poorest of the poor.

At this event, Global Health Experts will comment on Japan’s First Public-Private Partnership to Advance Global Health R&D.

AGENDA

George Jagoe, MBA, Moderator

Executive Vice President for Access and Product Management, Medicines for Malaria Venture

OPENING REMARKS

Masato Mugitani, MD, MPH

Assistant Minister for Global Health, Ministry of Health, Labour and Welfare, Japan

PANEL

BT Slingsby, MD, PhD, MPH

Executive Director & CEO, Global Health Innovative Technology Fund

Bernard Pécoul, MD, MPH

Executive Director, Drugs for Neglected Disease initiative

David Reddy, PhD

CEO, Medicines for Malaria Venture

The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board. The main functions of the World Health Assembly are to determine the policies of the Organization, appoint the Director-General, supervise financial policies, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva, Switzerland.